Despite its pivotal role in tumor immunology, PRMT5 has been shown to be unable to modulate PD-L1 gene transcription through histone methylation (H3R2, H3R8, and H4R3) in cervical cancer cells [24, 25]. The gene discussed is PRMT5; the disease is neoplasm.